Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...

High-yield bargain opportunities exist for disciplined, value-focused investors. Read more about the two standout stocks I've ...

The biotech industry can be volatile even for relatively large companies. Amgen (NASDAQ: AMGN), one of the more prominent ...

Next-generation sequencing allows for critical insights into gene therapy products, which can help streamline and accelerate ...

LSU football was handed a gut-wrenching loss in Week 11 by No. 11 Alabama, a loss that significantly impacted its College Football Playoff odds and path. Already dealing with a small room for ...

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Flashes of Navy and Gold ran all over Florida State football as Notre Dame handed the Seminoles a 52-3 loss Saturday night. In front of a nearly sold-out Notre Dame Stadium, the Fighting Irish (8 ...

The market didn't appreciate Amgen 's ( AMGN 1.00%) latest clinical data update, with the biopharma's shares falling more ...

KFF Health News staffers and contributors made the rounds on national and local media this week to discuss their stories.

According to phase 2 study, MariTide achieved significant weight loss in individuals with obesity or overweight, with up to ...

New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in ...